Sheets Smith Investment Management’s Eton Pharmaceutcials ETON Stock Holding History

Sheets Smith Investment Management’s Portfolio ETON Stock Details ETON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$323K	Buy	+14,842	New	+$246K	0.21%	98

Other funds holding ETON

Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

NPT

National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Sheets Smith Investment Management's ETON Position: Q3 2025 in Review

Sheets Smith Investment Management opened a new position in Eton Pharmaceutcials (ETON) in Q3 2025: 14,842 shares worth $323K. The stake represents 0.21% of the portfolio and ranks #98 among its holdings.

103 funds tracked by Wall St. Rank hold ETON as of Q3 2025.

Sheets Smith Investment Management held 14,842 shares of Eton Pharmaceutcials worth $323K as of Q3 2025.
Eton Pharmaceutcials was a new Sheets Smith Investment Management position in Q3 2025.
Eton Pharmaceutcials made up 0.21% of Sheets Smith Investment Management's portfolio in Q3 2025, its #98 holding.
103 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2025.

Based on Sheets Smith Investment Management's 13F filing for Q3 2025, filed 8 Oct 2025.